Nazli Dizman
@NazliDizman
MD & Researcher | Heme/Onc fellow @MDAndersonNews | @YaleIMed ‘23 | Postdoc @cityofhope @montypal | @ASCOTECAG | #WomenInMedicine | T/RT my own
ID:733782620958511105
https://coi.asco.org/share/J7C-BSUP/Nazli%20Dizman 20-05-2016 22:13:04
17,0K Tweets
8,1K Followers
5,6K Following
We are having our ASCO State Affiliate Council #SAC meeting! A lot of discussions about delivering the best care to our patients
It is encouraging to see how much state societies care for #hemonc fellows! ASCOTECAG
cc Fernando Diaz, MD Jacob J. Adashek, DO Ana I. Velázquez Mañana, MD MSc (she/her/ella) Nazli Dizman
Sumanta K. Pal, MD, FASCO ASCO MOASC Toni Choueiri, MD Neeraj Agarwal, MD, FASCO Vivek Subbiah, MD Nazli Dizman Ana I. Velázquez Mañana, MD MSc (she/her/ella) Shilpa Gupta Dr. Ravi Salgia Congrats Sumanta K. Pal, MD, FASCO , you’re perfect for this role and couldn’t think of any one more suited!
Congrats Stephen Kimani, MD, MSc and team on this thoughtful contribution on #GlobalOncology ! Huntsman Cancer Institute
Very happy that Melissa M Wolf's paper on how loss of VHL in kidney cancer cells reshapes the tumor immune microenvironment to recruit suppressive macrophages & point to a new immunotherapy target in RCC is out in Journal of Clinical Investigation
Vanderbilt-Ingram Cancer Center
VUMC_VCI
jci.org/articles/view/…
Tour de force presentation today by Dr. Katy Rezvani Katy Rezvani, M.D., Ph.D at the Allison Institute MD Anderson Cancer Center encompassing great science and a proliferative pipeline of cell therapies for our patients with heme and solid cancers! #NK #celltherapy
Excited to see Arya Roy co-leading this effort to help us understand & advance workforce diversity! Way to bring data to an important issue
And, so excited Arya Roy is joining The James Breast Onc Team this fall💯
CC: Margaret Gatti-Mays MD MPH FACP Sagar Sardesai Dionisia Quiroga, DO, PhD Nicole Williams MD
Thank you, ASCO for naming me an Advocacy Champion at the #ASCOAdvocacySummit along with many amazing colleagues & advocates!
Proud to advocate for ⬆️ funding for #CancerResearch , policies to prevent & end chemotherapy shortages, and expanded access to #Telehealth services…
Thank you ASCO for naming me a 2023 Advocacy Champion at the #ASCOAdvocacySummit along w/ incredible colleagues & friends Amanda Nizam, MD Ana I. Velázquez Mañana, MD MSc (she/her/ella) Sumanta K. Pal, MD, FASCO Fernando Diaz, MD et al. While unable to join this year's summit, I am proud to continue to fight to improve cancer care!
I am proud to announce that I have been named an Advocacy Champion at the #ASCOAdvocacy Summit ! This past year I engaged with my local representatives to improve care for patients w #cancer . #ASCOAdvocacy
Next up on our program calendar - the virtual grant writing workshop! Applications due May 1 #SWOGonc
We invite participants across the #NCTN - open to members of NRG Oncology ECOG-ACRIN Cancer Research Group Children’s Oncology Group Alliance for Clinical Trials in Oncology too! Please encourage colleagues to apply! w/SWOG Cancer Research Network
thehopefoundation.org/funding-opport…
🎊What a great way to start the week❗️😃
🎊I am super excited & humbled to be featured in the #RisingStars section of the April 2024 Issue of the Oncology Compass Digest. Mine is a story of #mentorship & #sponsorship !
Full article:
🔗:oncologycompass.com/digest/issue9/…
#FlorezLab 🫶
Excited to be participating in the ASCO advocacy summit representing Oklahoma to highlight issues on drug shortages, telehealth flex and Research! OU Health Stephenson Cancer Center ASCOTECAG IMG Oncologists. Looking forward to meeting Sen. James Lankford Rep. Tom Cole Tom Cotton Markwayne Mullin
✈️ Heading to DC with ASCO & team #California for the
#ASCOAdvocacySummit !
We are advocating for:
🔑Action to mitigate drug shortages
🔑Continuation of #telehealth flexibilities
🔑Robust #CancerResearch funding
➡️ You can join us virtually at asco.quorum.us/actioncenter/
April marks #TesticularCancer Awareness Month 💜
We are so excited to welcome Dr. Larry Einhorn from IU Simon Comprehensive Cancer Center, a true legend when it comes to the treatment of Germ Cell Tumors, for our next 2 episodes!
He shares board review pearls & words of wisdom for trainees.
Don't miss MedNewsWeek's exciting Keynote Conference, in collaboration with OncLive.com, as we showcase the amazing work of Dr. Annie Im of University of Pittsburgh discussing the latest developments in AML therapies.